Results: 1-23 |
Results: 23

Authors: Syme, RM Bryan, TL Gluck, S
Citation: Rm. Syme et al., Dendritic cell-based therapy: A review focusing on antigenic selection, J HEMATH ST, 10(5), 2001, pp. 601-608

Authors: Syme, RM Duggan, P Stewart, D Gluck, S
Citation: Rm. Syme et al., Generation of dendritic cells ex vivo: Differences in steady state versus mobilized blood from patients with breast cancer, with lymphoma, and from normal donors, J HEMATH ST, 10(5), 2001, pp. 621-630

Authors: Syme, R Gluck, S
Citation: R. Syme et S. Gluck, Effects of cytokines on the culture and differentiation of dendritic cellsin vitro, J HEMATH ST, 10(1), 2001, pp. 43-51

Authors: Syme, R Gluck, S
Citation: R. Syme et S. Gluck, Generation of dendritic cells: role of cytokines and potential clinical applications, TRANSF AP S, 24(2), 2001, pp. 117-124

Authors: Eimuller, T Fischer, P Kohler, M Scholz, M Guttmann, P Denbeaux, G Gluck, S Bayreuther, G Schmahl, G Attwood, D Schutz, G
Citation: T. Eimuller et al., Transmission X-ray microscopy using X-ray magnetic circular dichroism, APPL PHYS A, 73(6), 2001, pp. 697-701

Authors: Carlson, LE Koski, T Gluck, S
Citation: Le. Carlson et al., Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer, BONE MAR TR, 27(9), 2001, pp. 989-998

Authors: Bewick, M Conlon, M Gerard, S Lee, H Parissenti, AM Zhang, L Gluck, S Lafrenie, RM
Citation: M. Bewick et al., HER-2 expression is a prognostic factor in patients with metastatic breastcancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support, BONE MAR TR, 27(8), 2001, pp. 847-853

Authors: Stewart, DA Guo, D Luider, J Auer, I Klassen, J Morris, D Brown, CB Chaudhry, A Gluck, S Russell, JA
Citation: Da. Stewart et al., The CD3(-)16(+)56(+) NK cell count independently predicts autologous bloodstem cell mobilization, BONE MAR TR, 27(12), 2001, pp. 1237-1243

Authors: Kassam, G Kwon, M Yoon, YS Graham, KS Young, MK Gluck, S Waisman, DM
Citation: G. Kassam et al., Purification and characterization of A(61) - An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors, J BIOL CHEM, 276(12), 2001, pp. 8924-8933

Authors: Rock, G Chin-Yee, I Cantin, G Giulivi, A Gluck, S Keating, A Keeny, M Klassen, J Sutherland, R
Citation: G. Rock et al., Quality assurance of progenitor cell content of apheresis products: a comparison of clonogenic assays and CD34+enumeration, TRANSFUS M, 10(1), 2000, pp. 67-75

Authors: Schimmer, AD Jamal, S Messner, H Keating, A Meharchand, J Huebsch, L Walker, I Benger, A Gluck, S Smith, A
Citation: Ad. Schimmer et al., Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy, BONE MAR TR, 26(8), 2000, pp. 859-864

Authors: Stewart, DA Guo, D Gluck, S Morris, D Chaudhry, A deMetz, C Klassen, J Brown, CB Russell, JA
Citation: Da. Stewart et al., Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation, BONE MAR TR, 26(4), 2000, pp. 383-388

Authors: Duggan, PR Guo, D Luider, J Auer, I Klassen, J Chaudhry, A Morris, D Gluck, S Brown, CB Russell, JA Stewart, DA
Citation: Pr. Duggan et al., Predictive factors for long-term engraftment of autologous blood stem cells, BONE MAR TR, 26(12), 2000, pp. 1299-1304

Authors: Stewart, DA Guo, D Luider, J Auer, I Klassen, J Morris, D Chaudhry, A Brown, C Russell, JA Gluck, S
Citation: Da. Stewart et al., The CD34(+)90(+) cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34(+) cell dose, BONE MAR TR, 25(4), 2000, pp. 435-440

Authors: Gluck, S Stewart, D
Citation: S. Gluck et D. Stewart, High-dose therapy in breast cancer: out of favor but not out of promise, BONE MAR TR, 25(10), 2000, pp. 1017-1019

Authors: Chadderton, A Villeneuve, DJ Gluck, S Kirwan-Rhude, AF Gannon, BR Blais, DE Parissenti, AM
Citation: A. Chadderton et al., Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells, BREAST CANC, 59(3), 2000, pp. 231-244

Authors: Gluck, S
Citation: S. Gluck, Ex vivo expansion of hematopoietic stem cells, J HEMATH ST, 8(6), 1999, pp. 575-575

Authors: Goss, P Stewart, AK Couture, F Klasa, R Gluck, S Kaizer, L Burkes, R Charpentier, D Palmer, M Tye, L Dulude, H
Citation: P. Goss et al., Combined results of two phase II studies of Taxol (R) (paclitaxel) in patients with relapsed or refractory lymphomas, LEUK LYMPH, 34(3-4), 1999, pp. 295-304

Authors: Gluck, S Stewart, D
Citation: S. Gluck et D. Stewart, What's happening? Current status of high dose chemotherapy in breast cancer, TRANSFUS SC, 21(3), 1999, pp. 211-214

Authors: Theriault, RL Lipton, A Hortobagyi, GN Leff, R Gluck, S Stewart, JF Costello, S Kennedy, I Simeone, J Seaman, JJ Knight, RD Mellars, K Heffernan, M Reitsma, DJ
Citation: Rl. Theriault et al., Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomized, placebo-controlled trial, J CL ONCOL, 17(3), 1999, pp. 846-854

Authors: Bewick, M Chadderton, T Conlon, M Lafrenie, R Morris, D Stewart, D Gluck, S
Citation: M. Bewick et al., Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support, BONE MAR TR, 24(4), 1999, pp. 377-384

Authors: Parissenti, AM Gannon, BR Villeneuve, DJ Kirwan-Rhude, AF Chadderton, A Gluck, S
Citation: Am. Parissenti et al., Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant MCF-7 breast cancer cells, INT J CANC, 82(6), 1999, pp. 893-900

Authors: Sorel, M Gluck, S Laybourn, PJR
Citation: M. Sorel et al., Semiconductor double ring waveguide resonators, ELECTR LETT, 35(18), 1999, pp. 1551-1552
Risultati: 1-23 |